journal article·2023-12-31Open access

Liposomes for drug delivery: review of vesicular composition, factors affecting drug release and drug loading in liposomes

Shantanu Pande

Abstract

Liposomes are considered among the most versatile and advanced nanoparticle delivery systems used to target drugs to specific cells and tissues. Structurally, liposomes are sphere-like vesicles of phospholipid molecules that are surrounded by equal number of aqueous compartments. The spherical shell encapsulates an aqueous interior which contains substances such as peptides and proteins, hormones, enzymes, antibiotics, antifungal and anticancer agents. This structural property of liposomes makes it an important nano-carrier for drug delivery. Extrusion is one of the most frequently used technique for preparing monodisperse uni-lamellar liposomes as the technique is used to control vesicle size. The process involves passage of lipid suspension through polycarbonate membrane with a fixed pore size to produce vesicles with a diameter near the pore size of the membrane used in preparing them. An advantage of this technique is that there is no need to remove the organic solvent or detergent from the final preparation. This review focuses on composition of liposome formulation with special emphasis on factors affecting drug release and drug-loading.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Drug Product Technical Services, Wave Life Sciences, Lexington, MA, USA

References (100+)

Show source-provided references
1. 10.1016/j.jconrel.2018.12.02910.1016/j.jconrel.2018.12.029 ↗
2. 10.3389/fphar.2015.0028610.3389/fphar.2015.00286 ↗
3. 10.1016/j.jconrel.2013.03.03610.1016/j.jconrel.2013.03.036 ↗
4. 10.4155/tde.10.1310.4155/tde.10.13 ↗
5. 10.1186/s12951-018-0392-810.1186/s12951-018-0392-8 ↗
6. 10.1186/1556-276X-8-10210.1186/1556-276X-8-102 ↗
7. 10.1124/pr.115.01207010.1124/pr.115.012070 ↗
8. 10.3109/21691401.2014.95363310.3109/21691401.2014.953633 ↗
9. 10.1016/j.ajps.2014.09.00410.1016/j.ajps.2014.09.004 ↗
10. 10.3390/pharmaceutics1212123510.3390/pharmaceutics12121235 ↗
11. 10.3390/pharmaceutics1003013910.3390/pharmaceutics10030139 ↗
12. 10.3390/molecules2304090710.3390/molecules23040907 ↗
13. 10.1038/s41598-018-33107-510.1038/s41598-018-33107-5 ↗
14. 10.1080/1071754049026524310.1080/10717540490265243 ↗
15. 10.1038/srep0500510.1038/srep05005 ↗
16. 10.1016/0014-5793(80)80819-210.1016/0014-5793(80)80819-2 ↗
17. 10.1021/acs.bioconjchem.6b0043710.1021/acs.bioconjchem.6b00437 ↗
18. Rajani C · Pharmaceut Appl Dendrimer · 2019 · 2020 · 151
19. 10.1016/j.addr.2018.07.00710.1016/j.addr.2018.07.007 ↗
20. 10.1016/s0168-3659(99)00248-510.1016/s0168-3659(99)00248-5 ↗
21. 10.1002/jps.2406110.1002/jps.24061 ↗
22. 10.3389/fmicb.2016.0135510.3389/fmicb.2016.01355 ↗
23. Gabizon AA. · Clin Cancer Res · 2001 · 7 · 223
24. Immordino ML · Int J Nanomedicine · 2006 · 1 · 29710.2217/17435889.1.3.297 ↗
25. 10.3109/0898210950901023310.3109/08982109509010233 ↗
26. 10.1039/C3TB21238F10.1039/C3TB21238F ↗
27. 10.1016/S0006-3495(02)75255-710.1016/S0006-3495(02)75255-7 ↗
28. 10.1016/j.jconrel.2018.02.04010.1016/j.jconrel.2018.02.040 ↗
29. Huwyler J · Int J Nanomedicine · 2008 · 3 · 2110.2147/IJN.S1253 ↗
30. 10.1098/rsif.2014.045910.1098/rsif.2014.0459 ↗
31. 10.1021/la702096310.1021/la7020963 ↗
32. 10.1007/978-1-4939-6591-5_210.1007/978-1-4939-6591-5_2 ↗
33. 10.1155/2020/546294910.1155/2020/5462949 ↗
34. 10.5772/intechopen.9325610.5772/intechopen.93256 ↗
35. 10.1155/2014/42423910.1155/2014/424239 ↗
36. 10.1021/acs.molpharmaceut.8b0128410.1021/acs.molpharmaceut.8b01284 ↗
37. 10.3390/pharmaceutics902001210.3390/pharmaceutics9020012 ↗
38. 10.4172/2155-952X.100027610.4172/2155-952X.1000276 ↗
39. 10.2147/IJN.S6886110.2147/IJN.S68861 ↗
40. 10.2217/nnm.13.11810.2217/nnm.13.118 ↗
41. Lindner LH · Curr Opin Drug Discov Devel · 2010 · 13 · 111
42. 10.2217/17460875.1.1.2510.2217/17460875.1.1.25 ↗
43. Drummond DC · Pharmacol Rev · 1999 · 51 · 691
44. 10.1002/ejlt.20180003910.1002/ejlt.201800039 ↗
45. 10.1016/j.fct.2018.01.01710.1016/j.fct.2018.01.017 ↗
46. 10.1021/jp201611p10.1021/jp201611p ↗
47. 10.1016/s0168-3659(00)00240-610.1016/s0168-3659(00)00240-6 ↗
48. 10.1007/s13346-015-0220-810.1007/s13346-015-0220-8 ↗
49. 10.1042/BSR2009010410.1042/BSR20090104 ↗
50. 10.1016/j.bbamem.2014.05.02910.1016/j.bbamem.2014.05.029 ↗
51. 10.3390/ma511230610.3390/ma5112306 ↗
52. 10.3390/nano607012510.3390/nano6070125 ↗
53. 10.1016/0005-2736(90)90440-y10.1016/0005-2736(90)90440-y ↗
54. 10.1155/2011/37654810.1155/2011/376548 ↗
55. 10.1186/s12645-019-0055-y10.1186/s12645-019-0055-y ↗
56. 10.3390/pharmaceutics1203026410.3390/pharmaceutics12030264 ↗
57. 10.1038/s41598-018-31693-y10.1038/s41598-018-31693-y ↗
58. 10.1016/j.ijpharm.2016.03.04410.1016/j.ijpharm.2016.03.044 ↗
59. 10.1080/08982104.2017.134383610.1080/08982104.2017.1343836 ↗
60. 10.1016/j.bbamem.2007.01.01910.1016/j.bbamem.2007.01.019 ↗
61. 10.1002/wnan.145010.1002/wnan.1450 ↗
62. 10.18632/oncotarget.1755910.18632/oncotarget.17559 ↗
63. 10.1016/0168-3659(88)90020-X10.1016/0168-3659(88)90020-X ↗
64. 10.1021/acsbiomaterials.7b0025510.1021/acsbiomaterials.7b00255 ↗
65. 10.1097/GOX.000000000000173910.1097/GOX.0000000000001739 ↗
66. 10.3390/pharmaceutics1003015010.3390/pharmaceutics10030150 ↗
67. 10.1039/c9tb02470k10.1039/c9tb02470k ↗
68. 10.2147/IJN.S4929710.2147/IJN.S49297 ↗
69. 10.1016/j.jconrel.2013.01.02610.1016/j.jconrel.2013.01.026 ↗
70. 10.1016/j.ejpb.2018.09.01010.1016/j.ejpb.2018.09.010 ↗
71. 10.1155/2019/264592810.1155/2019/2645928 ↗
72. 10.1021/mp500186a10.1021/mp500186a ↗
73. 10.2217/nnm-2018-051010.2217/nnm-2018-0510 ↗
74. 10.1158/1535-7163.MCT-15-086710.1158/1535-7163.MCT-15-0867 ↗
75. 10.2478/afpuc-2019-000910.2478/afpuc-2019-0009 ↗
76. 10.15616/BSL.2019.25.2.15910.15616/BSL.2019.25.2.159 ↗
77. 10.3390/pharmaceutics1003015110.3390/pharmaceutics10030151 ↗
78. 10.1016/j.colsurfb.2019.04.03510.1016/j.colsurfb.2019.04.035 ↗
79. 10.1517/17425247.2011.56655210.1517/17425247.2011.566552 ↗
80. 10.1016/j.ijpharm.2004.07.01010.1016/j.ijpharm.2004.07.010 ↗
81. 10.1007/s11095-014-1551-810.1007/s11095-014-1551-8 ↗
82. 10.1016/0009-3084(86)90077-010.1016/0009-3084(86)90077-0 ↗
83. 10.1016/j.apsb.2018.06.00510.1016/j.apsb.2018.06.005 ↗
84. 10.3168/jds.2012-607210.3168/jds.2012-6072 ↗
85. 10.1042/BST2019012310.1042/BST20190123 ↗
86. 10.1080/1071754049028076910.1080/10717540490280769 ↗
87. 10.1016/0169-409X(89)90024-010.1016/0169-409X(89)90024-0 ↗
88. 10.1107/S090904951302082710.1107/S0909049513020827 ↗
89. 10.1166/jcsb.2012.102010.1166/jcsb.2012.1020 ↗
90. 10.1590/1678-4324-201615047710.1590/1678-4324-2016150477 ↗
91. 10.1073/pnas.132413511110.1073/pnas.1324135111 ↗
92. 10.3390/pharmaceutics1109046510.3390/pharmaceutics11090465 ↗
93. Popovska O · Int J Pharmaceut Phytopharmacol Res · 2013 · 3 · 182
94. 10.1016/j.jconrel.2017.03.01010.1016/j.jconrel.2017.03.010 ↗
95. 10.2217/nnm.16.3710.2217/nnm.16.37 ↗
96. 10.1016/s0168-3659(98)00052-210.1016/s0168-3659(98)00052-2 ↗
97. 10.1186/s11671-019-2964-410.1186/s11671-019-2964-4 ↗
98. 10.1021/ja806555710.1021/ja8065557 ↗
99. 10.1371/journal.pone.010311610.1371/journal.pone.0103116 ↗
100. 10.22270/jddt.v8i5-s.193510.22270/jddt.v8i5-s.1935 ↗